News

Biolog patent

Biolog patent

US company Biolog this week received a patent for its Phenotype
MicroArray technology. The patent, number US 6,472,201, is granted
for comparative phenotypic analysis of two or more microorganisms
using a number of substrates within...

Shea nut to beat swellings

Shea nut to beat swellings

Danish vegetable oils and fats company Aarhus Oliefabrik announced
yesterday that together with Astion, it will increase the
development portfolio of BSP Pharma principally using oil from the
African shea nut.

IVAX remains 'active'

IVAX remains 'active'

Pharmaceutical and veterinary product manufacturer IVAX corporation
has acquired ChemSource, a manufacturer of active pharmaceutical
ingredients based in Puerto Rico.

Rhodia losses

Rhodia losses

French specialty chemicals company Rhodia today reported net sales
of €6,617 million in 2002, representing a nine per cent drop
compared with 2001.

Patent for HCS

Patent for HCS

High Content Screening company Cellomics announced today that the
Canadian Intellectual Property Office has issued Cellomics'
Canadian Patent No. 2,328,194 entitled 'A System for Cell-Based
Screening.'

Valentis wins ruling

Valentis wins ruling

US Valentis announced that its wholly-owned subsidiary, PolyMASC
Pharmaceuticals, has received a favourable ruling from the Japanese
Patent Office in regard to patent invalidation proceedings brought
by ALZA Corporation, a unit of...

Ecopia discovery

Ecopia discovery

Canadian drug development company Ecopia BioSciences on Monday
announced that it had filed patent applications for the first two
novel compounds using its proprietary drug discovery platform -
suggesting investments by the company...

Voridian contract for Eastman

Voridian contract for Eastman

Emerson Process Management has received a multi-year contract from
Voridian, a division of Eastman Chemical, to upgrade automation
systems at Voridian's polyethylene terephthalate (PET) polymers
plants in Columbia and in Cosoleacaque,...

Degussa divestments complete

Degussa divestments complete

German chemicals company Degussa has sold its Frankfurt/Main-based
biopharmaceutical company Zentaris to Canadian firm AEterna
Laboratories for approximately €50 million, the company said last
week. The move marks the much-talked...

Follow us

Products

View more

Webinars